Recent advances of tubulin inhibitors targeting the colchicine binding site for cancer therapy

M Hawash - Biomolecules, 2022 - mdpi.com
Cancer accounts for numerous deaths each year, and it is one of the most common causes
of death worldwide, despite many breakthroughs in the discovery of novel anticancer …

Recent progress in biological activities of indole and indole alkaloids

TP Singh, OM Singh - Mini reviews in medicinal chemistry, 2018 - ingentaconnect.com
The indole scaffold is found in a wide range of bioactive heterocycles and natural products.
Moreover, the indole moiety is considered as the active principle in several alkaloids such …

An overview of tubulin inhibitors that interact with the colchicine binding site

Y Lu, J Chen, M Xiao, W Li, DD Miller - Pharmaceutical research, 2012 - Springer
Tubulin dynamics is a promising target for new chemotherapeutic agents. The colchicine
binding site is one of the most important pockets for potential tubulin polymerization …

Renal drug transporters and drug interactions

A Ivanyuk, F Livio, J Biollaz, T Buclin - Clinical pharmacokinetics, 2017 - Springer
Transporters in proximal renal tubules contribute to the disposition of numerous drugs.
Furthermore, the molecular mechanisms of tubular secretion have been progressively …

Indole, a core nucleus for potent inhibitors of tubulin polymerization

A Brancale, R Silvestri - Medicinal research reviews, 2007 - Wiley Online Library
Microtubules are the basic components of cell structure, which take part in a wide number of
pivotal cellular functions. Drugs that are able to modulate the microtubule assembly either by …

Blocking blood flow to solid tumors by destabilizing tubulin: an approach to targeting tumor growth

MJ Pérez-Pérez, EM Priego, O Bueno… - Journal of medicinal …, 2016 - ACS Publications
The unique characteristics of the tumor vasculature offer the possibility to selectively target
tumor growth and vascularization using tubulin-destabilizing agents. Evidence accumulated …

Dual inhibitors of histone deacetylases and other cancer-related targets: A pharmacological perspective

Y Gao, H Zhang, F Lirussi, C Garrido, XY Ye… - Biochemical …, 2020 - Elsevier
Epigenetic enzymes histone deacetylases (HDACs) are clinically validated anticancer drug
targets which have been studied intensively in the past few decades. Although several drugs …

Coumarin-based drugs: a patent review (2008–present)

C Kontogiorgis, A Detsi… - Expert opinion on …, 2012 - Taylor & Francis
Introduction: Coumarins are a group of plant-derived polyphenolic compounds. They belong
to the benzopyrones family and possess a wide variety of cytoprotective and modulatory …

Hypoxia‐inducible factor‐1α contributes to hypoxia‐induced chemoresistance in gastric cancer

L Liu, X Ning, L Sun, H Zhang, Y Shi, C Guo… - Cancer …, 2008 - Wiley Online Library
Hypoxia induced drug resistance is a major obstacle in the development of effective cancer
therapy. Our previous study revealed that hypoxia‐inducible factor‐1 (HIF‐1), the major …

Treat cancers by targeting survivin: just a dream or future reality?

MS Coumar, FY Tsai, JR Kanwar, S Sarvagalla… - Cancer treatment …, 2013 - Elsevier
Since the discovery of survivin (BIRC5) as a cancer-related molecule by Grazia Ambrosini
and Dario C. Altieri at 1997, our knowledge related to the function of this molecule has been …